MoneyWorks4Me

Kilitch Drugs (India) informs about details of loss of certificate

18 Dec 2023 Evaluate
Pursuant to Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirement) Regulations, 2015, Kilitch Drugs (India) has informed that the Company has received request for issuance of duplicate share certificate from the Registrar and Share Transfer Agents of the Company, Link intime India as details enclosed.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..